France-Paris: Research and experimental development services
Prior information notice
This notice is for prior information only
Section I: Contracting authority
Main address: www.resah.fr
Address of the buyer profile: www.relief-chronicpain.eu
Main address: www.akademiska.se
Main address: www.juntadeandalucia.es
Address of the buyer profile: www.imibic.org
Section II: Object
Pre-commercial procurement (PCP) to buy research and development (R&D) services to improve chronic pain self-management through the development of innovative ICT solution(s) addressing actual need(s).
Develop and test eHealth solutions for improving chronic pain self-management.
Priorities of intervention have been identified such as care coordination, assessment and measurement, self-management, monitoring, information and education. Although there is a wide range of high-tech devices aimed at treating pain, it is still necessary to cover the gap between Research and Commercialization. Only a small percentage of the existing solutions are clinically validated. A wide variety of ICT could provide solutions to this challenge.
RELIEF is mainly focused on technologies improving self-care, which go beyond the standard telecare and telehealth, virtual reality, augmented reality, apps, remote access to therapist, gamification, etc. These technologies could lead to personalized medicine and improve patient safety enhancing the efficiency of the public healthcare system.
RESAH will act as the lead procurer and will lead the joint procurement in the name and on behalf of CCU and SAS. The procurement will be a PCP under which R&D services contracts will be awarded to providers in parallel in a phased approach. Each selected operator will be awarded a framework agreement that cover 3 (three) R&D phases: phase A solution design, Phase B prototype development and Phase C pre-commercial development.
After each phase, intermediate evaluations will be carried out to progressively selecting the best of the competing solutions. The best-value-for-money solutions will be offered a specific contract for the next phase. Testing will be carry out in France, Sweden and Spain.
PCP Launch is expected in February 2017.
More details concerning the RELIEF PCP call and the procedure: https://ec.europa.eu/digital-single-market/en/pre-commercial-procurement
All Applications must be submitted at least in English and additionally can be submitted in French.
Open Market Consultation (OMC) information will be available on the RELIEF website: http://relief-chronicpain.eu/
An online questionnaire will be available on the RELIEF website from the 1st November until 31st December and 3 specific Workshops will be held:
— France: Paris 1st December;
— Spain: Cordoba 14th December;
— Sweden: Uppsala 9th December.
Section IV: Procedure
Section VI: Complementary information
This procurement is funded by the European Union's Horizon 2020 Research and Innovation Programme, under grant agreement No 689476 RELIEF see: http://relief-chronicpain.eu/
The EU has given a grant for this procurement but is not participating in the procurement.
The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws implemented them (because it concerns the procurement of R&D services where the benefits do no accrue exclusively to the contracting authority for its use in the conduct of its own affairs).
This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.
You can participate in the PCP call for tender even if you do not participate in the open market consultation (OMC).